10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0000203077-16-000020`
Period End Date	20160630
Filing Date	20160803
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	stj-20160702.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 97 Cash Flow Statement 72 Comprehensive Income 40

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$46.00M	USD	Point-in-time
Accounts receivable allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$46.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.44B	USD	Point-in-time
Preferred stock, par value (USD per share)	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$667.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$398.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$910.00M	USD	Point-in-time
Preferred stock, par value (USD per share)	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $46 at both July 2, 2016 and January 2, 2016	`AccountsReceivableNetCurrent`	$1.24B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $46 at both July 2, 2016 and January 2, 2016	`AccountsReceivableNetCurrent`	$1.33B	USD	Point-in-time
Finished goods	`InventoryFinishedGoodsNetOfReserves`	$609.00M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Finished goods	`InventoryFinishedGoodsNetOfReserves`	$563.00M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Work in process	`InventoryWorkInProcessNetOfReserves`	$105.00M	USD	Point-in-time
Work in process	`InventoryWorkInProcessNetOfReserves`	$102.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Raw materials	`InventoryRawMaterialsNetOfReserves`	$198.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Raw materials	`InventoryRawMaterialsNetOfReserves`	$236.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	283.45M	shares	Point-in-time
Inventories	`InventoryNet`	$909.00M	USD	Point-in-time
Inventories	`InventoryNet`	$904.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	284.60M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	283.45M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	284.60M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$269.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$295.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.08B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.93B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.77B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.89B	USD	Point-in-time
Less: Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.45B	USD	Point-in-time
Less: Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.56B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.33B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.32B	USD	Point-in-time
Goodwill	`Goodwill`	$5.67B	USD	Point-in-time
Goodwill	`Goodwill`	$5.65B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.15B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.23B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$589.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$621.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$12.90B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$12.66B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$660.00M	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$1.16B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$201.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$242.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$201.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	-	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$811.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$901.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.47B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.71B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$5.43B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$5.23B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.23B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.16B	USD	Point-in-time
Total liabilities	`Liabilities`	$8.38B	USD	Point-in-time
Total liabilities	`Liabilities`	$8.86B	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 284,596,998 and 283,450,374 shares issued and outstanding at July 2, 2016 and January 2, 2016, respectively)	`CommonStockValueOutstanding`	$28.00M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 284,596,998 and 283,450,374 shares issued and outstanding at July 2, 2016 and January 2, 2016, respectively)	`CommonStockValueOutstanding`	$28.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$148.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$232.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.37B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.21B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-345.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-347.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.28B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.24B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.84B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.04B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$12.66B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$12.90B	USD	Point-in-time

Income Statement 97 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$1.41B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$2.75B	USD	2 Qtrs
Net sales	`SalesRevenueNet`	$3.01B	USD	2 Qtrs
Net sales	`SalesRevenueNet`	$1.56B	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$419.00M	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$974.00M	USD	2 Qtrs
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$812.00M	USD	2 Qtrs
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$490.00M	USD	1 Quarter
Special charges	`SpecialCharges`	$5.00M	USD	1 Quarter
Special charges	`SpecialCharges`	$7.00M	USD	2 Qtrs
Special charges	`SpecialCharges`	$9.00M	USD	2 Qtrs
Special charges	`SpecialCharges`	$6.00M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$424.00M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$819.00M	USD	2 Qtrs
Total cost of sales	`CostOfGoodsSold`	$496.00M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$983.00M	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.07B	USD	1 Quarter
Gross profit	`GrossProfit`	$986.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.03B	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.94B	USD	2 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$502.00M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$447.00M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$877.00M	USD	2 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$993.00M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$380.00M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$338.00M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$192.00M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$171.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$46.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$24.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$48.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$92.00M	USD	2 Qtrs
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$30.00M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$34.00M	USD	2 Qtrs
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$13.00M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$21.00M	USD	2 Qtrs
Operating profit	`OperatingIncomeLoss`	$313.00M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$314.00M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$639.00M	USD	2 Qtrs
Operating profit	`OperatingIncomeLoss`	$541.00M	USD	2 Qtrs
Interest income	`InterestIncome`	$1.00M	USD	2 Qtrs
Interest income	`InterestIncome`	-	USD	1 Quarter
Interest income	`InterestIncome`	$1.00M	USD	2 Qtrs
Interest income	`InterestIncome`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$41.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$40.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$20.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$80.00M	USD	2 Qtrs
Other (income) expense	`OtherNonoperatingIncomeExpense`	$-3.00M	USD	1 Quarter
Other (income) expense	`OtherNonoperatingIncomeExpense`	$-56.00M	USD	2 Qtrs
Other (income) expense	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other (income) expense	`OtherNonoperatingIncomeExpense`	$3.00M	USD	2 Qtrs
Other expense, net	`OtherExpenseNet`	$20.00M	USD	1 Quarter
Other expense, net	`OtherExpenseNet`	$43.00M	USD	1 Quarter
Other expense, net	`OtherExpenseNet`	$135.00M	USD	2 Qtrs
Other expense, net	`OtherExpenseNet`	$37.00M	USD	2 Qtrs
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$602.00M	USD	2 Qtrs
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$270.00M	USD	1 Quarter
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$406.00M	USD	2 Qtrs
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$294.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$73.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$64.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$12.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$32.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$538.00M	USD	2 Qtrs
Net earnings before noncontrolling interest	`ProfitLoss`	$238.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$282.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$333.00M	USD	2 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-8.00M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-14.00M	USD	2 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$552.00M	USD	2 Qtrs
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$290.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$238.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$333.00M	USD	2 Qtrs
Basic (USD per share)	`EarningsPerShareBasic`	$1.03	USD	1 Quarter
Basic (USD per share)	`EarningsPerShareBasic`	$0.84	USD	1 Quarter
Basic (USD per share)	`EarningsPerShareBasic`	$1.17	USD	2 Qtrs
Basic (USD per share)	`EarningsPerShareBasic`	$1.96	USD	2 Qtrs
Diluted (USD per share)	`EarningsPerShareDiluted`	$1.93	USD	2 Qtrs
Diluted (USD per share)	`EarningsPerShareDiluted`	$1.02	USD	1 Quarter
Diluted (USD per share)	`EarningsPerShareDiluted`	$0.83	USD	1 Quarter
Diluted (USD per share)	`EarningsPerShareDiluted`	$1.16	USD	2 Qtrs
Cash dividends declared per share (USD per share)	`CommonStockDividendsPerShareDeclared`	$0.29	USD	1 Quarter
Cash dividends declared per share (USD per share)	`CommonStockDividendsPerShareDeclared`	$0.58	USD	2 Qtrs
Cash dividends declared per share (USD per share)	`CommonStockDividendsPerShareDeclared`	$0.31	USD	1 Quarter
Cash dividends declared per share (USD per share)	`CommonStockDividendsPerShareDeclared`	$0.31	USD	Point-in-time
Cash dividends declared per share (USD per share)	`CommonStockDividendsPerShareDeclared`	$0.62	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	284.30M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	281.10M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	282.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	283.90M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	288.30M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	287.30M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	286.30M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	285.50M	shares	1 Quarter

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net earnings before noncontrolling interest	`ProfitLoss`	$538.00M	USD	2 Qtrs
Net earnings before noncontrolling interest	`ProfitLoss`	$238.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$282.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$333.00M	USD	2 Qtrs
Depreciation of property, plant and equipment	`Depreciation`	$108.00M	USD	2 Qtrs
Depreciation of property, plant and equipment	`Depreciation`	$116.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$92.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$48.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$46.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$24.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$37.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$60.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-17.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-29.00M	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$104.00M	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-67.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$87.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$63.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$53.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$18.00M	USD	2 Qtrs
Other current and noncurrent assets	`IncreaseDecreaseInOtherOperatingAssets`	$11.00M	USD	2 Qtrs
Other current and noncurrent assets	`IncreaseDecreaseInOtherOperatingAssets`	$53.00M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$43.00M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-35.00M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-122.00M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-20.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$463.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$441.00M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$80.00M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$114.00M	USD	2 Qtrs
Business combination payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$11.00M	USD	2 Qtrs
Business combination payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	$8.00M	USD	2 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	-	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$4.00M	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$4.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-76.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-129.00M	USD	2 Qtrs
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$89.00M	USD	2 Qtrs
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$22.00M	USD	2 Qtrs
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$3.00M	USD	2 Qtrs
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$14.00M	USD	2 Qtrs
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	2 Qtrs
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$170.00M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$158.00M	USD	2 Qtrs
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$460.00M	USD	2 Qtrs
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$-117.00M	USD	2 Qtrs
Proceeds from debt	`ProceedsFromIssuanceOfLongTermDebt`	$500.00M	USD	2 Qtrs
Proceeds from debt	`ProceedsFromIssuanceOfLongTermDebt`	$175.00M	USD	2 Qtrs
Payments of debt	`RepaymentsOfLongTermDebt`	$726.00M	USD	2 Qtrs
Payments of debt	`RepaymentsOfLongTermDebt`	$750.00M	USD	2 Qtrs
Purchase of shares from noncontrolling interest	`PaymentsToMinorityShareholders`	-	USD	2 Qtrs
Purchase of shares from noncontrolling interest	`PaymentsToMinorityShareholders`	$173.00M	USD	2 Qtrs
Payment of contingent consideration	`Paymentofcontingentconsiderationfinancingactivities`	-	USD	2 Qtrs
Payment of contingent consideration	`Paymentofcontingentconsiderationfinancingactivities`	$125.00M	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-15.00M	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-858.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-613.00M	USD	2 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$10.00M	USD	2 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-39.00M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-269.00M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-532.00M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$910.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$667.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$398.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$667.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$398.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$910.00M	USD	Point-in-time

Comprehensive Income 40 line items

Line Item	Tag	Value	Unit	Period
Net earnings before noncontrolling interest	`ProfitLoss`	$538.00M	USD	2 Qtrs
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-1.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$238.00M	USD	1 Quarter
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	1 Quarter
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	2 Qtrs
Net earnings before noncontrolling interest	`ProfitLoss`	$282.00M	USD	1 Quarter
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-1.00M	USD	2 Qtrs
Net earnings before noncontrolling interest	`ProfitLoss`	$333.00M	USD	2 Qtrs
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-1.00M	USD	1 Quarter
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-2.00M	USD	1 Quarter
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$3.00M	USD	2 Qtrs
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-16.00M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities, net of tax (expense) benefit $-, $1, $- and $1, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities, net of tax (expense) benefit $-, $1, $- and $1, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.00M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities, net of tax (expense) benefit $-, $1, $- and $1, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.00M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net of tax (expense) benefit $-, $1, $- and $1, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-4.00M	USD	1 Quarter
Unrealized gain (loss) on derivative financial instruments, net of tax (expense) benefit of $1, $2, $16 and ($3), respectively	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$12.00M	USD	2 Qtrs
Unrealized gain (loss) on derivative financial instruments, net of tax (expense) benefit of $1, $2, $16 and ($3), respectively	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-34.00M	USD	2 Qtrs
Unrealized gain (loss) on derivative financial instruments, net of tax (expense) benefit of $1, $2, $16 and ($3), respectively	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-17.00M	USD	1 Quarter
Unrealized gain (loss) on derivative financial instruments, net of tax (expense) benefit of $1, $2, $16 and ($3), respectively	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-4.00M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$30.00M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$31.00M	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-17.00M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-97.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-88.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$9.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-2.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-20.00M	USD	1 Quarter
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$218.00M	USD	1 Quarter
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$291.00M	USD	1 Quarter
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$450.00M	USD	2 Qtrs
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$331.00M	USD	2 Qtrs
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-8.00M	USD	1 Quarter
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-14.00M	USD	2 Qtrs
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$464.00M	USD	2 Qtrs
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$299.00M	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$218.00M	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$331.00M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.